[go: up one dir, main page]

WO1990010709A3 - Anticorps monoclonaux pour cations metalliques sur petites molecules - Google Patents

Anticorps monoclonaux pour cations metalliques sur petites molecules Download PDF

Info

Publication number
WO1990010709A3
WO1990010709A3 PCT/US1990/001401 US9001401W WO9010709A3 WO 1990010709 A3 WO1990010709 A3 WO 1990010709A3 US 9001401 W US9001401 W US 9001401W WO 9010709 A3 WO9010709 A3 WO 9010709A3
Authority
WO
WIPO (PCT)
Prior art keywords
monoclonal antibodies
metallic cations
small molecules
hybridomas
small
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US1990/001401
Other languages
English (en)
Other versions
WO1990010709A2 (fr
Inventor
Fred W Wagner
Dwane E Wylie
Sheldon M Schuster
Thomas R Coolidge
Pill-Soon Song
William Parker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Nebraska Lincoln
University of Nebraska System
Original Assignee
University of Nebraska Lincoln
University of Nebraska System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23263379&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=WO1990010709(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by University of Nebraska Lincoln, University of Nebraska System filed Critical University of Nebraska Lincoln
Priority to DE69031909T priority Critical patent/DE69031909T2/de
Priority to EP90905954A priority patent/EP0463110B1/fr
Priority to AU54114/90A priority patent/AU648022B2/en
Priority to CA002047717A priority patent/CA2047717C/fr
Publication of WO1990010709A2 publication Critical patent/WO1990010709A2/fr
Publication of WO1990010709A3 publication Critical patent/WO1990010709A3/fr
Priority to FI914298A priority patent/FI100472B/fi
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54353—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/84—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving inorganic compounds or pH
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/55—Fab or Fab'

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Inorganic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Endoscopes (AREA)
  • Pressure Sensors (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

L'invention concerne des anticorps monoclonaux, leurs fragments, des chaînes individuelles et des imitateurs polypeptidiques de leurs régions hypervariables immuniréagissant avec des petites fractions simples telles que des cations métalliques et des petites molécules organiques, les hybridomes permettant la production des anticorps monoclonaux, des composés immunogènes permettant de développer les hybridomes, ainsi que des procédés d'utilisation des anticorps monoclonaux.
PCT/US1990/001401 1989-03-14 1990-03-14 Anticorps monoclonaux pour cations metalliques sur petites molecules Ceased WO1990010709A2 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
DE69031909T DE69031909T2 (de) 1989-03-14 1990-03-14 Monoklonale antikörper für metall kationen
EP90905954A EP0463110B1 (fr) 1989-03-14 1990-03-14 Anticorps monoclonaux contre des cations metalliques
AU54114/90A AU648022B2 (en) 1989-03-14 1990-03-14 Monoclonal antibodies for metallic cations on small molecules
CA002047717A CA2047717C (fr) 1989-03-14 1990-03-14 Anticorps monoclonaux contre de petites molecules et methodes pour les preparer
FI914298A FI100472B (fi) 1989-03-14 1991-09-12 Monoklonaalisia vasta-aineita metallikationeille

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32439289A 1989-03-14 1989-03-14
US324,392 1989-03-14

Publications (2)

Publication Number Publication Date
WO1990010709A2 WO1990010709A2 (fr) 1990-09-20
WO1990010709A3 true WO1990010709A3 (fr) 1990-11-15

Family

ID=23263379

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1990/001401 Ceased WO1990010709A2 (fr) 1989-03-14 1990-03-14 Anticorps monoclonaux pour cations metalliques sur petites molecules

Country Status (9)

Country Link
US (1) US5503987A (fr)
EP (2) EP0589487A1 (fr)
JP (1) JPH05504464A (fr)
AT (1) ATE161852T1 (fr)
AU (1) AU648022B2 (fr)
CA (1) CA2047717C (fr)
DE (1) DE69031909T2 (fr)
FI (1) FI100472B (fr)
WO (1) WO1990010709A2 (fr)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5972656A (en) * 1989-03-14 1999-10-26 Bionebraska, Inc. Mercury binding polypeptides and nucleotides coding therefore
DE4007079A1 (de) * 1990-03-07 1991-09-12 Behringwerke Ag Monoklonale antikoerper gegen komplexierte und nicht komplexierte komplexbildner zur entfernung von schwermetallen aus waessrigen loesungen
WO1992004633A1 (fr) * 1990-09-05 1992-03-19 Neurex Corporation Procede et composition servant a detecter des peptides bioactifs
US5273909A (en) * 1991-06-03 1993-12-28 Quantix Systems, L.P. Immunoassay for the detection of small aliphatic organic compounds
US5532136A (en) * 1993-06-22 1996-07-02 Bionebraska, Inc. Monoclonal antibody assay and kit for detecting metal cations in body fluids
US5459040A (en) * 1993-11-22 1995-10-17 The Regents Of The University Of California Enzyme amplified, complex linked, competitive and non-competitive assays for the detection of metal ions
US5476939A (en) * 1993-12-30 1995-12-19 Abbott Laboratories Certain pyridyl and isoquinolyl carbinolamine derivatives
AU1695795A (en) * 1994-01-27 1995-08-15 Bionebraska, Inc. Mercury binding polypeptides and nucleotides coding therefor
AU6094696A (en) * 1995-06-05 1996-12-24 Bionebraska, Inc. Lead binding polypeptides and nucleotides coding therefor
US6111079A (en) * 1995-06-05 2000-08-29 Bionebraska, Inc. Lead binding polypeptides and nucleotides coding therefore
US5817527A (en) * 1995-11-06 1998-10-06 Chiron Diagnostics Corporation Conjugation of ligand to immobilized protein in organic solvent
US5962291A (en) * 1996-04-19 1999-10-05 The Regents Of The University Of Colorado Metal dependent catalytic antibodies and method for producing the same
US5989839A (en) * 1996-08-19 1999-11-23 Ghassan I. Shaker Use of MOLT4 CD69 expression to determine the presence and activity of interferon inhibitors
US6190923B1 (en) 1997-09-05 2001-02-20 David K. Johnson Diethylenetriamine-N,N′,N″-triacetic acid derivatives
US7387772B1 (en) * 1999-06-22 2008-06-17 Immunimedics, Inc. Chimeric, human and humanized anti-CSAP monoclonal antibodies
WO1999066951A2 (fr) * 1998-06-22 1999-12-29 Immunomedics, Inc. Utilisation d'anticorps bi-specifiques pour diagnostic et therapie de pre-ciblage
US6962702B2 (en) * 1998-06-22 2005-11-08 Immunomedics Inc. Production and use of novel peptide-based agents for use with bi-specific antibodies
US7833528B2 (en) * 1998-06-22 2010-11-16 Immunomedics, Inc. Use of multispecific, non-covalent complexes for targeted delivery of therapeutics
US7138103B2 (en) * 1998-06-22 2006-11-21 Immunomedics, Inc. Use of bi-specific antibodies for pre-targeting diagnosis and therapy
US7405320B2 (en) 1998-06-22 2008-07-29 Immunomedics, Inc. Therapeutic and diagnostic conjugates for use with multispecific antibodies
US7070937B1 (en) 1998-10-02 2006-07-04 Ischemia Technologies, Inc. Marker useful for detection and measurement of free radical damage and method
US20030215359A1 (en) * 1998-10-02 2003-11-20 Ischemia Technologies, Inc. Tests for the rapid evaluation of ischemic states and kits
US7449338B2 (en) * 1998-10-02 2008-11-11 Ischemia Technologies, Inc. Tests for the rapid evaluation of ischemic states and kits
US6475743B1 (en) 1998-10-02 2002-11-05 Ischemia Technologies, Inc. Marker useful for detection and measurement of free radical damage and method
US20050142613A1 (en) * 1998-10-02 2005-06-30 David Bar-Or Test for the rapid evaluation of ischemic states and kits
US20030215952A1 (en) 1998-10-02 2003-11-20 Ischemia Technologies, Inc. Tests for the rapid evaluation of ischemic states and kits
US20020199218A1 (en) * 1999-08-19 2002-12-26 Daphne Goring Proline-rich extensin-like receptor kinases
US7592304B2 (en) 1999-10-01 2009-09-22 Dmi Life Sciences, Inc. Metal-binding compounds and uses therefor
US7632803B2 (en) 1999-10-01 2009-12-15 Dmi Life Sciences, Inc. Metal-binding compounds and uses therefor
US20030130185A1 (en) * 2000-09-29 2003-07-10 David Bar-Or Metal-binding compounds and uses therefor
US20030158111A1 (en) * 1999-10-01 2003-08-21 David Bar-Or Methods and products for oral care
CA2364983A1 (fr) * 2000-12-13 2002-06-13 John R. Coleman Molecules d'acide nucleique et polypeptides pour le catabolisme de l'acide abscisique
WO2002048675A2 (fr) * 2000-12-15 2002-06-20 Transderm Technologies, Llc Compositions ameliorees et procedes pour produire des anticorps d'analytes a faible masse moleculaire
US7597895B2 (en) * 2001-02-20 2009-10-06 The Governing Council Of The University Of Toronto Signal peptides, nucleic acid molecules and methods for treatment of caries
US7556807B2 (en) 2001-02-20 2009-07-07 Kane Biotech, Inc. Signal peptides, nucleic acid molecules and methods for treatment of caries
US6686202B2 (en) * 2001-08-08 2004-02-03 Placer Dome, Inc. Methods for detecting and extracting gold
WO2003050143A1 (fr) * 2001-12-11 2003-06-19 Expressive Constructs, Inc. Detection et elimination du plomb au moyen de proteines de liaison du plomb
US7833731B2 (en) * 2004-03-31 2010-11-16 Canon Kabushiki Kaisha Gold-binding protein and use thereof
US8021849B2 (en) * 2004-11-05 2011-09-20 Siemens Healthcare Diagnostics Inc. Methods and kits for the determination of sirolimus in a sample
US20090075342A1 (en) * 2005-04-26 2009-03-19 Sharon Cload Metabolic profile directed aptamer medicinal chemistry
US7189582B2 (en) * 2005-04-27 2007-03-13 Dade Behring Inc. Compositions and methods for detection of sirolimus
EP2445932B1 (fr) 2009-06-26 2018-02-28 Soricimed Biopharma Inc. Peptides dérivés de la soricidine, procédés de détection de cancers exprimant trpv-6 et administration de médicament
CN113801220B (zh) * 2021-09-18 2023-07-07 青岛普瑞邦生物工程有限公司 一种米酵菌酸复合抗原、米酵菌酸抗体及其制备方法和酶联免疫试剂盒
CN114014934B (zh) * 2021-10-14 2023-05-05 江苏省农业科学院 多氯联苯单克隆抗体及其应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0235457A2 (fr) * 1985-12-13 1987-09-09 Syngene International N.V. Anticorps monoclonaux
US4722892A (en) * 1984-08-31 1988-02-02 Meares Claude F Monoclonal antibodies against metal chelates

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5599072A (en) * 1979-01-24 1980-07-28 Mitsubishi Petrochem Co Ltd Production of artificial antigen containing choline residue
US4281065A (en) * 1979-01-25 1981-07-28 Syva Company Phencyclidine conjugates to antigenic proteins and enzymes
US4261974A (en) * 1979-11-13 1981-04-14 Miles Laboratories, Inc. Valproic acid immunogen conjugates and antibodies thereto
JPS5714748A (en) * 1980-07-01 1982-01-26 Dainippon Pharmaceut Co Ltd Kit for quantitative determination of valproic acid and its method for quantitative determination
US4608337A (en) * 1980-11-07 1986-08-26 The Wistar Institute Human hybridomas and the production of human monoclonal antibodies by human hybridomas
US4474893A (en) * 1981-07-01 1984-10-02 The University of Texas System Cancer Center Recombinant monoclonal antibodies
JPS5838860A (ja) * 1981-08-31 1983-03-07 Dainippon Pharmaceut Co Ltd バルプロ酸の定量に用いるキツト及びその方法
US4681782A (en) * 1982-03-31 1987-07-21 Biostar Medical Products, Inc. Article for determining the presence of immune complexes
US4454106A (en) * 1982-06-07 1984-06-12 Gansow Otto A Use of metal chelate conjugated monoclonal antibodies
US4472509A (en) * 1982-06-07 1984-09-18 Gansow Otto A Metal chelate conjugated monoclonal antibodies
GB2131830A (en) * 1982-12-10 1984-06-27 Ludwig Inst Cancer Res Monoclonal antibody for use against breast cancer
US4456691A (en) * 1983-02-28 1984-06-26 Suad Stark Antigen for PCB, antibody raised by same, and method of making same
US4778752A (en) * 1983-10-11 1988-10-18 Scripps Clinic And Research Foundation Receptors specific for hapten-modified self proteins
FR2557458B1 (fr) * 1983-12-30 1987-09-04 Centre Nat Rech Scient Nouveaux anticorps capables de reconnaitre specifiquement des groupements hapteniques, leur preparation et leur application, et nouveaux antigenes permettant de les preparer
US4701408A (en) * 1984-01-30 1987-10-20 Smithkline Beckman Corporation Monoclonal antibody to activated macrophages
FR2561660B1 (fr) * 1984-03-26 1986-07-25 Centre Nat Rech Scient Nouveaux anticorps diriges contre un groupement haptenique contenant un motif choline, leur preparation et leur application, et nouveaux antigenes permettant de les preparer
US4764359A (en) * 1984-05-25 1988-08-16 Lemelson Jerome H Drug compositions and their use in treating human or other mammalian patients
DE3582961D1 (de) * 1984-06-27 1991-07-04 Johnson Matthey Plc Platinkoordinationsverbindungen.
EP0169645A1 (fr) * 1984-06-27 1986-01-29 Johnson Matthey Public Limited Company Composés de coordination du platine
CA1260827A (fr) * 1984-08-31 1989-09-26 Richard C. Siegel Complexes anticorps - ions metalliques
US4530786A (en) * 1984-09-04 1985-07-23 Colorado State University Research Foundation Antibody for the detection and quantification of atrazine
WO1986002736A1 (fr) * 1984-10-29 1986-05-09 Eks, Inc. Procede d'analyse immunologique pour petites molecules
JPS61145200A (ja) * 1984-12-19 1986-07-02 Snow Brand Milk Prod Co Ltd ウシラクトフェリンの分離精製法
AU5444386A (en) * 1985-03-08 1986-09-11 Baylor College Of Medicine Anti-nicotine and anti-cotinine antibodies (monoclonal and polyclonal)
US4677070A (en) * 1985-04-26 1987-06-30 Cetus Corporation Pseudomonas aeruginosa exotoxin A antibodies, their preparation and use
DE3515901A1 (de) * 1985-05-03 1986-11-06 Battelle-Institut E.V., 6000 Frankfurt Verfahren zum nachweis von 1, 2, 2-trimethylpropylmethylphosphofluoridad
CA1302919C (fr) * 1985-07-03 1992-06-09 Robert T. Buckler Derives de l'histamine, conjugues immunogenes et antibiotiques obtenus a partir de ceux-ci
JPS6251699A (ja) * 1985-08-30 1987-03-06 Nichirei:Kk 単クロ−ン性抗体およびそれを用いる測定法
US4772551A (en) * 1985-12-26 1988-09-20 Neogen Corporation Method and test kit for detecting a trichothecene using novel monoclonal antibodies
US4797473A (en) * 1986-06-25 1989-01-10 Regents Of The University Of Minnesota Monoclonal antibodies to unreduced, nonenzymatically-glycated proteins
DE3632343A1 (de) * 1986-09-24 1988-04-07 Battelle Institut E V Verfahren zum nachweis von 1,2,2-trimethylpropylmethylphosphofluoridad
US4859613A (en) * 1986-11-12 1989-08-22 Lawrence David A Immunoassays for glutathione and antibodies useful therein
US4793986A (en) * 1987-02-25 1988-12-27 Johnson Matthey, Inc. Macromolecular platinum antitumor compounds
CA1339946C (fr) * 1987-03-31 1998-07-07 Michael J. Griffith Methode d'ultrapurification pour les polypeptides

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4722892A (en) * 1984-08-31 1988-02-02 Meares Claude F Monoclonal antibodies against metal chelates
EP0235457A2 (fr) * 1985-12-13 1987-09-09 Syngene International N.V. Anticorps monoclonaux

Also Published As

Publication number Publication date
EP0463110A1 (fr) 1992-01-02
AU5411490A (en) 1990-10-09
EP0589487A1 (fr) 1994-03-30
AU648022B2 (en) 1994-04-14
FI914298A0 (fi) 1991-09-12
US5503987A (en) 1996-04-02
CA2047717C (fr) 2000-08-01
JPH05504464A (ja) 1993-07-15
DE69031909D1 (de) 1998-02-12
EP0463110B1 (fr) 1998-01-07
CA2047717A1 (fr) 1990-09-15
WO1990010709A2 (fr) 1990-09-20
FI100472B (fi) 1997-12-15
DE69031909T2 (de) 1998-04-16
ATE161852T1 (de) 1998-01-15

Similar Documents

Publication Publication Date Title
WO1990010709A3 (fr) Anticorps monoclonaux pour cations metalliques sur petites molecules
ATE208820T1 (de) Humanisierte antikoerper
DE69633973D1 (de) Antikörper gegen die alpha-kette von humanem interleukin 5 rezeptor
PL313260A1 (en) Monoclonal antibodies having properties making them able to cause apoptosis
BR9809778A (pt) Polinucleotìdeo isolado, vetor de expressão, peptìdeo ou polipetìdeo isolado, anticorpo, processo para produzir o mesmo, fragmentos de anticorpos, anticorpos de cadeia única ou anticorpos humanizados, e, anticorpo anti-idiotìpico.
ES551495A0 (es) Procedimiento de obtencion de un anticuerpo monoclonal reactivo con antigenos de esporozoitos o merozoitos de eimeria spp.
PT85490A (en) Process for the preparation of specific monoclonal antibodies of apolipoprotein-b and essay processes for the determination o the above mentioned apolipoprotein
PT94575A (pt) Processo para a preparacao de novas citoquinas
DE3177276D1 (de) Monoklonale antikoerper.
PT840620E (pt) Antagonistas de il-8 para o tratamento de asma
PT90323A (pt) Processo para a preparacao de anticorpos monoclonais
ZA905132B (en) Monoclonal and polyclonal antibodies and test method for determination of fenitrothion and closely related organophosphates
DE3365284D1 (en) Process for the sequence analysis by mass spectroscopy of a, if necessary modified oligoribonucleotide or oligodesoxyribonucleotide
EP0287397A3 (en) Monoclonal antibody specific to human pancreatic phospholipase a2
NO883854D0 (no) Monoklonalt antistoff og fremgangsmaate for dets fremstilling.
PT95856A (pt) Processo para a preparacao de novos anticorpos monoclonais anti-idiotipicos
BR8004767A (pt) Clinquer de cimento portland, processo para sua producao, processo de producao de cimento e cimento produzido pelo mesmo
WO2000064469A3 (fr) Utilisation de la glucose-6-phospate isomerase et de ses anticorps pour le diagnostic et le traitement de l'arthrite; essai de composes anti-arthritiques
FI91976C (fi) Menetelmä ja reagenssi follikkelia stimuloivan hormonin määrittämiseksi sekä tähän tarkoitukseen sopivat monoklonaaliset vasta-aineet
PT81050B (pt) Anticorpo monoclonal anti-urocinase e processo para a preparacao de composicoes de materia de teste biologicos que o utilizam
IT7920799A0 (it) Processo per la copolimerizzazione dell'etilene con idrocarburi pluriinsaturi.
DK156073C (da) Fremgangsmaade til fremstilling af kautsjuk-metalgenstande, isaer daek, kautsjukblanding til anvendelse ved fremgangsmaaden og ikke vulkaniseret kautsjuk-metalgenstand til udoevelse af fremgangsmaaden.
AU8264491A (en) Monoclonal antibodies to leptosphaeria
ES2059726T3 (es) Anticuerpos monoclonales que reconocen el itsp humano, hibridomas que producen los mismos, y su preparacion y uso.
BR8102151A (pt) Processo para o endurecimento ou tempera de pecas metalicas

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU CA DK FI HU JP KR NO SU

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FR GB IT LU NL SE

AK Designated states

Kind code of ref document: A3

Designated state(s): AU CA DK FI HU JP KR NO SU

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FR GB IT LU NL SE

CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i

Free format text: IN PAT.BUL.22/90,UNDER INID (54) TITLE REPLACE THE EXISTING TEXT BY "MONOCLONAL ANTIBODIES FOR METALLIC CATIONS ON SMALL MOLECULES"

WWE Wipo information: entry into national phase

Ref document number: 2047717

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 1990905954

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 914298

Country of ref document: FI

WWP Wipo information: published in national office

Ref document number: 1990905954

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 914298

Country of ref document: FI

WWG Wipo information: grant in national office

Ref document number: 1990905954

Country of ref document: EP

ENP Entry into the national phase

Ref country code: CA

Ref document number: 2047717

Kind code of ref document: A

Format of ref document f/p: F